Zusammenfassung
Depressionen (depressive Episoden und Dysthymien) werden im Kindes- und Jugendalter noch häufig als somatische Beschwerden unklarer Genese verkannt. Die Prävalenzzahlen zeigen jedoch weltweit, dass es sich um ein sehr häufiges Störungsbild handelt, das mittlerweile auch hinreichend valide diagnostizierbar ist. Neben der differenzialdiagnostischen Abklärung stellt die oft begleitend auftretende Suizidalität den behandelnden Arzt vor diagnostische und therapeutische Herausforderungen. Im Rahmen eines gut ausgewogenen multimodalen Therapieansatzes lassen sich Depressionen auch im Kindes- und Jugendalter gut behandeln. Dafür ist eine besonders sorgfältige Risiko-Nutzen-Abwägung der gewählten Interventionen (Psychoedukation, Psychotherapie, Pharmakotherapie) erforderlich.
Abstract
Depression (depressive episode and dysthymia) in children and adolescents is often misinterpreted diagnostically as somatic complaints of unknown cause and aetiology. Worldwide prevalence rates, however, have indicated that this disorder occurs very often and has sufficient diagnostic validity. In addition to the differential diagnosis a major diagnostic and therapeutic challenge for practitioners is the assessment of suicidality. In the context of well-balanced multimodal treatment, depression in children and adolescents can be treated effectively. However, it is essential to consider the risks and benefits of the chosen interventions (psychoeducation, psychotherapy, pharmacotherapy).
This is a preview of subscription content, log in via an institution to check access.
Literatur
Beardslee WR, Gladstone TR, O’Connor EE (2011) Transmission and prevention of mood disorders among children of affectively ill parents: a review. J Am Acad Child Adolesc Psychiatry 50(11):1098–1109
Bettge S, Wille N, Barkmann C et al (2008) Depressive symptoms of children and adolescents in a German representative sample: results of the BELLA study. Eur Child Adolesc Psychiatry [Suppl 1] 17:71–81
Birmaher B, Brent D, AACAP Work Group on Quality Issues (2007) Practice parameter for the assessment and treatmentof children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 46:11 (http://www.aacap.org/galleries/PracticeParameters/Vol%2046%20Nov%202007.pdf)
Costello EJ, Mustillo S, Erkanli A et al (2003) Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60(8):837–844
Epkins CC, Heckler DR (2011) Integrating etiological models of social anxiety and depression in youth: evidence for a cumulative interpersonal risk model. Clin Child Fam Psychol Rev 14(4):329–376
Joseph MR, Philip LH (2009) Depression in children and adolescents. In: Joseph MR, Boris B (Hrsg) Treating child and adolescent depression. Wolters Kluwer, Köln, S 3–16
Kirsch I, Deacon BJ, Huedo-Medina TB et al (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5(2):e45
Klein DN, Shankman SA, Rose S (2008) Dysthymic disorder and double depression: prediction of 10-year course trajectories and outcomes. J Psychiatr Res 42(5):408–415
Meyer RE, Salzman C, Youngstrom EA (2010) Suicidality and risk of suicide – definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry 71(8):e1–e21
Olfson M, Shaffer D, Marcus SC et al (2003) Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60(10):978–982
Parellada M, Moreno C, Moreno M (2011) Placebo effect in child and adolescent psychiatric trials. Eur Neuropsychopharmacol Oct 24. [Epub ahead of print]
Posner K, Oquendo MA, Gould M (2007) Columbia classification algorithm of suicide assessment (C-CASA): classification of suicidal events in the FDA’s pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164(7):1035–1043
Sondergard L, Kvist K, Andersen PK et al (2006) Do antidepressants precipitate youth suicide? A nationwide pharmacoepidemiological study. Eur Child Adolesc Psychiatry 15(4):232–240
Wagner KD (2005) Pharmacotherapy for major depression in children and adolescents. Prog Neuropsychopharmacol Biol Psychiatry 29:819–826
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehungen hin:
Beratungstätigkeit für die Firmen Shire und Lundbeck im Indikationsgebiet Depression, kein direkter Problembezug zum Artikel.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huss, M. Depressionen im Kindes- und Jugendalter. Monatsschr Kinderheilkd 160, 40–46 (2012). https://doi.org/10.1007/s00112-011-2513-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-011-2513-4